Design, synthesis, antimicrobial activity and computational studies of novel azo linked substituted benzimidazole, benzoxazole and benzothiazole derivatives. 2019

Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
Department of Dyestuff Technology, Institute of Chemical Technology, Matunga (E), Mumbai, Maharashtra, 400 019, India.

Novel azo linked substituted benzimidazole, benzoxazole, and benzothiazole were synthesized by diazo coupling and characterized by 1H NMR, elemental analysis, FTIR and UV-vis spectroscopy. The newly synthesized compounds were evaluated for invitro antibacterial activity against Staphylococcus aureus and Escherichia Coli strains by Resazurin microtiter assay method (REMA). The minimum inhibitory concentration (MIC in μg/mL) were used to express the antibacterial activities. The azo linked compounds exhibited good to moderate or high antibacterial activities in vitro. Computational studies were performed to correlate HOMO-LUMO gap with antibacterial activity. The comparative molecular docking studies revealed better insights into binding mechanisms.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001391 Azo Compounds Organic chemicals where aryl or alkyl groups are joined by two nitrogen atoms through a double bond (R-N Azo Dye,Azo Dyes,Compounds, Azo,Dye, Azo,Dyes, Azo
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D001583 Benzoxazoles Benzoxazole
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D052160 Benzothiazoles Compounds with a benzene ring fused to a thiazole ring.
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
December 1995, Arzneimittel-Forschung,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
January 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
August 1997, Die Pharmazie,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
February 2003, Bioorganic & medicinal chemistry letters,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
April 2014, European journal of medicinal chemistry,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
January 2012, Journal of fluorescence,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
January 2017, European journal of medicinal chemistry,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
January 2003, Arzneimittel-Forschung,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
January 2020, ACS combinatorial science,
Virendra R Mishra, and Chaitannya W Ghanavatkar, and Suraj N Mali, and Shahnawaz I Qureshi, and Hemchandra K Chaudhari, and Nagaiyan Sekar
January 2019, Iranian journal of pharmaceutical research : IJPR,
Copied contents to your clipboard!